South Tyrol Option Agreement

Arizona Sonoran and Nuton LLC Announce Option to Joint Venture on Cactus Project in Arizona

Retrieved on: 
Thursday, December 14, 2023

Arizona Sonoran Copper Company Inc. (TSX:ASCU | OTCQX:ASCUF) (“ASCU” or the “Company”) is pleased to announce today that it has entered into an option to joint venture agreement with Nuton LLC (“Nuton”), a wholly-owned subsidiary of Rio Tinto, to establish a strategic alliance for deployment of the Nuton technologies at its Cactus Mine and the Parks/Salyer Project (collectively, the “Cactus Project”), in Arizona, USA.

Key Points: 
  • Arizona Sonoran Copper Company Inc. (TSX:ASCU | OTCQX:ASCUF) (“ASCU” or the “Company”) is pleased to announce today that it has entered into an option to joint venture agreement with Nuton LLC (“Nuton”), a wholly-owned subsidiary of Rio Tinto, to establish a strategic alliance for deployment of the Nuton technologies at its Cactus Mine and the Parks/Salyer Project (collectively, the “Cactus Project”), in Arizona, USA.
  • Nuton has indicated the potential to significantly increase copper cathode output from our current 45-50 ktpa target which could materially enhance project economics.
  • In the event that Nuton exercises the Option, the parties will either form a Delaware limited liability company or deem Cactus to be the joint venture company for the Cactus Project (the “Joint Venture Corporation”).
  • Rothschild acted as financial advisor, and Torys LLP and Dorsey & Whitney LLP acted as legal advisors, to Nuton.

Skyharbour Partner Company Tisdale Clean Energy Plans Exploration Program at the South Falcon East Uranium Project, Athabasca Basin, Saskatchewan

Retrieved on: 
Wednesday, November 1, 2023

Vancouver, BC, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Skyharbour Resources Ltd. (TSX-V: SYH ) (OTCQX: SYHBF ) (Frankfurt: SC1P ) (“Skyharbour” or the “Company”) is pleased to announce that partner company Tisdale Clean Energy Corp. (“Tisdale”), plans to begin exploration at the South Falcon East Uranium Project which hosts the Fraser Lakes Zone B uranium deposit.

Key Points: 
  • Vancouver, BC, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Skyharbour Resources Ltd. (TSX-V: SYH ) (OTCQX: SYHBF ) (Frankfurt: SC1P ) (“Skyharbour” or the “Company”) is pleased to announce that partner company Tisdale Clean Energy Corp. (“Tisdale”), plans to begin exploration at the South Falcon East Uranium Project which hosts the Fraser Lakes Zone B uranium deposit.
  • The South Falcon East Project lies 18 km outside the edge of the Athabasca Basin, approximately 50 km east of the Key Lake uranium mill and former mine.
  • Map of South Falcon East Project Claims:
    Tisdale is planning an extensive preliminary drill program to commence in early 2024.
  • South Falcon East Project Summary:
    The South Falcon East Project is a uranium exploration project in the southeast Athabasca Basin and covers approximately 12,464 hectares.

Myriad Acquires Earnable 75% Interest in the Copper Mountain Uranium Project in Wyoming, USA

Retrieved on: 
Friday, October 20, 2023

The Property contains a number of other known uranium deposits and there is good potential to discover more.

Key Points: 
  • The Property contains a number of other known uranium deposits and there is good potential to discover more.
  • Rocky Mountain Energy, a subsidiary of Union Pacific, drilled approximately 2,000 boreholes at Copper Mountain between 1969 and 1980.
  • They spent upwards of US$78 million advancing Copper Mountain (2023 dollars), planned a mine for one of its deposits, and built a leach pad.
  • Finally, historical reports suggest the ore at Copper Mountain is leachable and does not require a mill, and it may even be ISR-amenable.

Brunswick Exploration Amends 1Minerals Agreement

Retrieved on: 
Friday, October 6, 2023

MONTREAL, Oct. 06, 2023 (GLOBE NEWSWIRE) -- Brunswick Exploration Inc. (TSX-V: BRW; OTCQB: BRWXF “BRW” or the “Company”) announces an amendment to its Option Agreement with 1Minerals Corp.

Key Points: 
  • MONTREAL, Oct. 06, 2023 (GLOBE NEWSWIRE) -- Brunswick Exploration Inc. (TSX-V: BRW; OTCQB: BRWXF “BRW” or the “Company”) announces an amendment to its Option Agreement with 1Minerals Corp.
  • The Option Agreement is now dated September 29, 2023 and milestone payments, which apply only to the claims under agreement with 1Minerals, are payable in cash, under the following schedule:

Mirasol Announces the Launch of Partner-Funded Drill Program at the Claudia Gold-Silver Project in Argentina

Retrieved on: 
Tuesday, October 3, 2023

(7.5%), has initiated a drill program at the Claudia Gold-Silver Project (“Claudia”), located directly south of the CVSA Gold-Silver Mine in the province of Santa Cruz, Argentina.

Key Points: 
  • (7.5%), has initiated a drill program at the Claudia Gold-Silver Project (“Claudia”), located directly south of the CVSA Gold-Silver Mine in the province of Santa Cruz, Argentina.
  • Under an Option Agreement, CVSA has the right to acquire a 100 percent interest in Claudia by completing 12,500 meters of diamond drilling within four years.
  • If the Option is exercised, Mirasol will retain a 2% Net Smelter Royalty on future production from the Claudia Project ( news release May 23, 2023 ).
  • Mirasol today also announces that the option agreement on the Homenaje Gold-Silver Project in Argentina (“Homenaje”) with Patagonia Gold Corp. (“Patagonia”) has been terminated.

Taysha Gene Therapies Provides Update on TSHA-120 Program in Giant Axonal Neuropathy (GAN)

Retrieved on: 
Tuesday, September 19, 2023

DALLAS, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system (CNS), today announced that subsequent to the receipt of Type C meeting feedback from the United States (U.S.) Food and Drug Administration (FDA) regarding a registrational path for TSHA-120, the Company will discontinue the development of its TSHA-120 program in evaluation for the treatment of giant axonal neuropathy (GAN). Further, Taysha announced that Astellas Gene Therapies, Inc. (f/k/a Audentes Therapeutics, Inc. (d/b/a Astellas Gene Therapy)) (Astellas) has elected not to exercise its option to obtain an exclusive license to TSHA-120 under the Option Agreement between Astellas and Taysha.

Key Points: 
  • Further, Taysha announced that Astellas Gene Therapies, Inc. (f/k/a Audentes Therapeutics, Inc. (d/b/a Astellas Gene Therapy)) (Astellas) has elected not to exercise its option to obtain an exclusive license to TSHA-120 under the Option Agreement between Astellas and Taysha.
  • “We believe we have made significant progress in demonstrating the therapeutic potential of TSHA-120 and identifying a potential registrational path.
  • FDA feedback included the need to address the heterogeneity of disease progression in GAN and the effort-dependent nature of MFM32 as a primary endpoint in an unblinded study.
  • FDA Type C meeting feedback indicated that the FDA continues to recommend a randomized, double-blind, placebo-controlled trial as the optimal path to demonstrate efficacy in TSHA-120.

Coinsilium Group Limited: Coinsilium to cornerstone funding round for AI powered Infrastructure Finance platform, Silta Finance AG

Retrieved on: 
Saturday, September 16, 2023

for AI powered Infrastructure Finance platform, Silta Finance AG

Key Points: 
  • for AI powered Infrastructure Finance platform, Silta Finance AG
    London, UK, 14 September 2023 - Coinsilium Group Limited (AQUIS: COIN) (OTCQB: CINGF), the Web3 investor, advisor, and venture builder is pleased to announce that the Company is to cornerstone a funding round for Switzerland-registered Silta Finance AG (“Silta”) via the Company’s 100% owned Gibraltar registered subsidiary, Seedcoin Limited ("Seedcoin").
  • Seedcoin signs Convertible Loan Agreement and Option Agreement with Silta as cornerstone investor in funding round.
  • Eddy Travia, Chief Executive of the Company commented:
    “We are delighted to further support Silta Finance and its highly experienced team led by Ben Sheppard in this latest funding round, as cornerstone investors.
  • “In the past year, Silta has meticulously crafted a proprietary model featuring 360 data points for evaluating the bankability of infrastructure projects.

TomaGold Corporation Receives Approval for Option of Chibougamau Independent’s West Block and LOI on East Block

Retrieved on: 
Wednesday, September 13, 2023

Chibougamau will retain a 2% Gross Metals Royalty (“GMR”) on the West Block, as will Globex Mining Enterprises Inc. (GMX-TSX) (“Globex”).

Key Points: 
  • Chibougamau will retain a 2% Gross Metals Royalty (“GMR”) on the West Block, as will Globex Mining Enterprises Inc. (GMX-TSX) (“Globex”).
  • Chibougamau is also pleased to announce that TomaGold has received approval of the letter of intent (“LOI”) for a potential sale of the East Block to TomaGold.
  • During the exclusivity period, TomaGold will be entitled to carry out a due diligence review of the East Block.
  • The LOI provides that TomaGold will grant a first-ranking hypothec to Chibougamau as security for payment of the cash purchase price for the East Block.

MANTARO PRECIOUS METALS CORP. ANNOUNCES TERMINATION OF OPTION AGREEMENT ON GOLDEN HILL PROPERTY AND RESIGNATION OF DIRECTOR

Retrieved on: 
Monday, August 28, 2023

Under the terms of the Option Agreement, the Company had the right to earn up to an 80% interest in the Golden Hill Property.

Key Points: 
  • Under the terms of the Option Agreement, the Company had the right to earn up to an 80% interest in the Golden Hill Property.
  • Concurrent with the delivery of the notice of termination, Mr. Kinn Cortez also resigned as a director of the Company.
  • Darren Hazelwood, Chief Executive Officer of the Company states "The current junior capital markets made it difficult to raise the capital necessary to meet the cash payments due under our Golden Hill property option agreement.
  • Under the Option Agreement, the Company will retain a 2% net smelter royalty on the Golden Hill Property, which may be repurchased by MGH with a one-time payment of US $1,000,000.

Adial Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Update

Retrieved on: 
Monday, August 21, 2023

Charlottesville, Va., Aug. 21, 2023 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today provided a business update and reported its financial results for the second quarter of 2023.

Key Points: 
  • Charlottesville, Va., Aug. 21, 2023 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today provided a business update and reported its financial results for the second quarter of 2023.
  • Moreover, the sale of our Purnovate business during the quarter provided non-dilutive funding and significantly reduced our current cash burn rate.
  • Adial received an upfront payment of $450 thousand on the notification date (May 8, 2023).
  • Net Income for the second quarter of 2023 included a gain of $2.66 million as a result of the Purnovate Sale.